Jump to Navigation

Facebook Connect

User login

2016 Spring CLU Highlights

Dr. James A. Underberg

PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia

Faculty: James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA

Tags:

Dr. James A. Underberg presents his talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia  

play
pdf
MP3 Audio
0
No votes yet
Dr. Kevin C. Maki

Key Clinical Lipidology Publications: 2015-16

Faculty: Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN

Tags:

Dr. Kevin C. Maki presents his talk at the 2015 Fall Clinical Lipid Update on Key Clinical Lipidology Publications: 2015-16

play
pdf
MP3 Audio
0
No votes yet
Dr. Terry A. Jacobson

Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?

Faculty: Terry A. Jacobson MD FACP FNLA

Tags:

Dr. Terry A. Jacobson presents his talk at the 2015 Fall Clinical Lipid Update on Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?

play
pdf
MP3 Audio
0
No votes yet
Dr. Anne Carol Goldberg

PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients

Faculty: Anne Carol Goldberg, MD, FNLA

Tags:

Dr. Anne Carol Goldberg presents her talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients 

play
pdf
MP3 Audio
0
No votes yet



by Dr. Radut.